4.8 Article

An integrated giant magnetoimpedance biosensor for detection of biomarker

期刊

BIOSENSORS & BIOELECTRONICS
卷 58, 期 -, 页码 338-344

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2014.03.008

关键词

Alpha-fetoprotein; Detection; Giant magnetoimpedance; Dynabeads; Au film; Self-assembled monolayer

资金

  1. National Natural Science Foundation of China [61074168, 61273065]
  2. National Science and Technology Support Program [2012BAK08B05]
  3. Natural Science Foundation of Shanghai [13ZR1420800]
  4. Analytical and Testing Center in Shanghai Jiao Tong University

向作者/读者索取更多资源

A Dynabeads-labeled magnetic immunoassay (MIA) has been developed by using an integrated giant magnetoimpedance (GMI) biosensor for the detection of alpha-fetoprotein (AFP). The GMI biosensor (Cr/Cu/NiFe/Cu/NiFe/Al2O3/Cr/Au films) integrated magnetic sensing elements and a biomolecular immunoplatform. Au film was modified with 11-Mercaptoundecanoic acid (11-MUA) for the immobilization of AFP monoclonal antibody. Double antibody sandwich immunoassay was used to specifically capture and label AFP antigen. Functionalized Dynabeads were conjugated to AFP antigen by streptavidin-biotin binding assay. GMI responses were measured for sensitive detection of AFP from 1 to 10 ng/ml. Our results revealed that the presence of AFP on the biosensor improved the GMI effect owing to the induced magnetic dipole of superparamagnetic Dynabeads, and the GMI ratio was greatly increased at high frequency. Specificity of MIA was tested through the use of 1% bovine serum albumin (BSA). The underlying biophysical mechanisms responsible for the enhanced GMI effect in the detection of APP were discussed. This work provides a complex lab-on-chip MIA for the detection of biomarker, which may open up a new way for the development of GMI-based MIA in clinical trials. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据